来自官方财务报表的收入、利润与现金流历史。
Koninklijke Philips N.V. 作为一家健康技术公司，在北美、大中华区和国际范围内运营。它通过诊断与治疗、互联护理和个人健康部门运营。该公司提供诊断成像解决方案，包括超声业务单元、磁共振成像、计算机断层扫描和诊断X射线；图像引导治疗，包括图像引导治疗系统和图像引导治疗设备。它还提供监控、企业信息学、睡眠和呼吸护理以及个人健康服务。 Koninklijke Philips N.V. 与 WellSpan Health 建立战略联盟，共同开发先进的成像和诊断技术产品和平台。该公司前身为 Koninklijke Philips Electronics N.V.，于 2013 年 5 月更名为 Koninklijke Philips N.V.。 Koninklijke Philips N.V. 成立于 1891 年，总部位于荷兰阿姆斯特丹。
机器翻译
| 利润表 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 总收入 | €17.7B | €17.8B | €18.0B | €18.2B | €17.8B | €17.2B | €17.3B | €17.1B | €18.1B | €17.8B | €24.5B | €24.2B | €21.4B | €23.3B | €24.8B | €22.6B | €25.4B | €23.2B | €26.4B | €26.8B | €27.0B |
| 毛利 | €8.1B | €8.1B | €7.8B | €7.4B | €7.2B | €7.2B | €7.9B | €7.9B | €8.6B | €8.2B | €10.6B | €9.9B | €8.2B | €9.7B | €9.4B | €8.6B | €9.5B | €8.1B | €8.5B | €9.2B | €8.3B |
| 毛利率% | 45.9% | 45.2% | 43.1% | 41.0% | 40.4% | 41.8% | 45.7% | 46.4% | 47.2% | 46.0% | 43.3% | 40.6% | 38.4% | 41.5% | 38.0% | 38.3% | 37.5% | 34.8% | 32.1% | 34.2% | 30.8% |
| 营业利润（EBIT） | €1.7B | €1.4B | €529M | (€115M) | (€1.5B) | €553M | €1.3B | €1.4B | €1.7B | €1.5B | €1.9B | €992M | €486M | €2.0B | €1.0B | (€269M) | €2.1B | €614M | €54M | €1.9B | €1.2B |
| 营业利润率% | 9.7% | 8.0% | 2.9% | -0.6% | -8.6% | 3.2% | 7.3% | 8.0% | 9.5% | 8.5% | 7.7% | 4.1% | 2.3% | 8.5% | 4.2% | -1.2% | 8.1% | 2.6% | 0.2% | 6.9% | 4.4% |
| 净利 | €1.1B | €895M | (€702M) | (€466M) | (€1.6B) | €3.3B | €1.2B | €1.2B | €1.1B | €1.7B | €1.4B | €645M | €415M | €1.2B | €226M | (€1.3B) | €1.4B | €410M | (€92M) | €4.2B | €5.4B |
| 净利润率 % | 6.3% | 5.0% | -3.9% | -2.6% | -9.0% | 19.4% | 6.9% | 6.8% | 6.0% | 9.3% | 5.9% | 2.7% | 1.9% | 5.0% | 0.9% | -5.7% | 5.7% | 1.8% | -0.4% | 15.6% | 20.0% |
| EBITDA | — | €2.6B | €1.8B | €1.0B | €115M | €2.0B | €2.8B | €2.6B | €2.8B | €2.6B | €2.4B | €1.8B | €1.8B | €3.1B | €1.9B | €1.0B | €3.6B | €2.3B | €656M | €2.7B | €2.0B |
| 每股收益（EPS） | €1.16 | €0.93 | €-0.75 | €-0.49 | €-1.69 | €3.49 | €1.24 | €1.20 | €1.09 | €1.64 | €1.46 | €0.66 | €0.42 | €1.19 | €0.23 | €-1.27 | €1.43 | €0.41 | €-0.09 | €3.57 | €4.27 |
| 已发行股数 (M) | — | 963M | 933M | 949M | 952M | 950M | 958M | 973M | 997M | 1,007M | 990M | 984M | 983M | 983M | 988M | 1,020M | 1,010M | 990M | 1,062M | 1,170M | 1,261M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 PHG 交互式查看器。 /companies/us/PHG
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms